COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...
Barchart on MSN2h
Earnings Preview: What to Expect From Moderna's ReportBased in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...
Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...
It is best to optimize the seasonal vaccines and therefore may administer the COVID-19 vaccine and the influenza vaccine on ...
High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...
Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...
Zylem Biosciences announced that Northwestern University has filed a lawsuit against Moderna (MRNA), alleging infringement of key patents ...
The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...
In last week’s column, I told you how the 2024 General Election (early voting has started) could lead to healthier, smarter, and longer lives for all of us (see: ...
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback